These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9057030)

  • 1. The effect of the vasodilator nicotinamide on cyclic nucleotide pathways in vascular smooth muscle.
    Burns DM; Ruddock MW; Brown JC; Kennovin GD; Dykes EL; Flitney FW; Hirst DG
    Biochem Soc Trans; 1997 Feb; 25(1):132S. PubMed ID: 9057030
    [No Abstract]   [Full Text] [Related]  

  • 2. A xanthine-based KMUP-1 with cyclic GMP enhancing and K(+) channels opening activities in rat aortic smooth muscle.
    Wu BN; Lin RJ; Lin CY; Shen KP; Chiang LC; Chen IJ
    Br J Pharmacol; 2001 Sep; 134(2):265-74. PubMed ID: 11564644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity.
    Galle J; Zabel U; Hübner U; Hatzelmann A; Wagner B; Wanner C; Schmidt HH
    Br J Pharmacol; 1999 May; 127(1):195-203. PubMed ID: 10369473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonidine-induced nitric oxide-dependent vasorelaxation mediated by endothelial alpha(2)-adrenoceptor activation.
    Figueroa XF; Poblete MI; Boric MP; Mendizábal VE; Adler-Graschinsky E; Huidobro-Toro JP
    Br J Pharmacol; 2001 Nov; 134(5):957-68. PubMed ID: 11682443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and charybdotoxin (CTX) on relaxations of isolated cerebral arteries to nitric oxide.
    Onoue H; Katusic ZS
    Brain Res; 1998 Feb; 785(1):107-13. PubMed ID: 9526059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cGMP hydrolysing phosphodiesterases 1 and 5 in cerebral artery dilatation.
    Kruuse C; Rybalkin SD; Khurana TS; Jansen-Olesen I; Olesen J; Edvinsson L
    Eur J Pharmacol; 2001 May; 420(1):55-65. PubMed ID: 11412839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1beta-induced, nitric oxide-dependent and -independent inhibition of vascular smooth muscle contraction.
    Takizawa S; Ozaki H; Karaki H
    Eur J Pharmacol; 1997 Jul; 330(2-3):143-50. PubMed ID: 9253947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of a novel, potent and selective phosphodiesterase 5 inhibitor, DMPPO: in vitro and in vivo characterization.
    Delpy E; le Monnier de Gouville AC
    Br J Pharmacol; 1996 Jul; 118(6):1377-84. PubMed ID: 8832060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ruthenium-nitrite complex as pro-drug releases NO in a tissue and enzyme-dependent way.
    Pereira Ade C; Ford PC; da Silva RS; Bendhack LM
    Nitric Oxide; 2011 May; 24(4):192-8. PubMed ID: 21440656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YC-1 potentiates the nitric oxide/cyclic GMP pathway in corpus cavernosum and facilitates penile erection in rats.
    Hsieh GC; O'Neill AB; Moreland RB; Sullivan JP; Brioni JD
    Eur J Pharmacol; 2003 Jan; 458(1-2):183-9. PubMed ID: 12498924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that additional mechanisms to cyclic GMP mediate the decrease in intracellular calcium and relaxation of rabbit aortic smooth muscle to nitric oxide.
    Weisbrod RM; Griswold MC; Yaghoubi M; Komalavilas P; Lincoln TM; Cohen RA
    Br J Pharmacol; 1998 Dec; 125(8):1695-707. PubMed ID: 9886761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of cyclic AMP-mediated vasorelaxation by phenylephrine in pulmonary arteries of the rat.
    Priest RM; Hucks D; Ward JP
    Br J Pharmacol; 1999 May; 127(1):291-9. PubMed ID: 10369485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
    Eckly AE; Lugnier C
    Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of guanylyl cyclase and protein kinase G inhibitors on vasodilatation in non-tolerant and tolerant bovine coronary arteries.
    De la Lande IS; Stafford I; Horowitz JD
    Eur J Pharmacol; 1999 Apr; 370(1):39-46. PubMed ID: 10323278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cyclic nucleotides in regulation of pulmonary artery tone in rabbits.
    Kapilevich LV; Nosarev AV; Kovalev IV; D'yakova EY; Baskakov MB
    Bull Exp Biol Med; 2003 Jun; 135(6):610-2. PubMed ID: 12937688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of vinpocetine (TCV-3B), a vasodilator agent, on cyclic nucleotide metabolism].
    Hagiwara M; Endo T; Hidaka H
    Nihon Yakurigaku Zasshi; 1982 Oct; 80(4):317-23. PubMed ID: 6130034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelium- and smooth muscle-dependent vasodilator effects of Citrus aurantium L. var. amara: Focus on Ca(2+) modulation.
    Kang P; Ryu KH; Lee JM; Kim HK; Seol GH
    Biomed Pharmacother; 2016 Aug; 82():467-71. PubMed ID: 27470386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relaxation induced by acetylcholine involves endothelium-derived hyperpolarizing factor in 2-kidney 1-clip hypertensive rat carotid arteries.
    Sendão Oliveira AP; Bendhack LM
    Pharmacology; 2004 Dec; 72(4):231-9. PubMed ID: 15539883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms underlying vasorelaxant action of astragaloside IV in isolated rat aortic rings.
    Zhang C; Wang XH; Zhong MF; Liu RH; Li HL; Zhang WD; Chen H
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):387-92. PubMed ID: 17439405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of cyclic nucleotides in renal artery smooth muscle relaxation.
    Karsten AJ; Derouet H; Ziegler M; Eckert RE
    Urol Res; 2003 Feb; 30(6):367-73. PubMed ID: 12599016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.